PubRank

I de Mascarel

Author PubWeight™ 23.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001 2.51
2 Metastases to the breast: differential diagnosis from primary breast carcinoma. J Surg Oncol 1991 2.02
3 Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987 1.97
4 The prognostic value of c-erbB2 in primary breast carcinomas: a study on 942 cases. Breast Cancer Res Treat 1995 1.46
5 Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi. Br J Cancer 1996 1.39
6 Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S100 protein and cytokeratin. J Pathol 1988 1.13
7 Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 1988 1.11
8 [Axillary lymph nodes in breast cancer. Comparison of standard histological analytical technics and macroscopic serial sections]. Bull Cancer 1982 1.03
9 Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases. Breast Cancer Res Treat 1999 0.96
10 Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987 0.95
11 [Male breast cancer: a review of 52 cases collected at the Institute Bergonié (Bordeaux, France) from 1980 to 2004]. Gynecol Obstet Fertil 2008 0.92
12 The prognostic significance of specific histologic features of carcinoma of the colon and rectum. Surg Gynecol Obstet 1981 0.91
13 Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases. Breast Cancer Res Treat 1995 0.90
14 Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease. Br J Cancer 1989 0.85
15 [Histological changes after chemotherapy of soft tissue sarcomas in the adult]. Ann Pathol 1985 0.83
16 Immunohistochemical determination of pS2 in invasive breast carcinomas: a study on 942 cases. Breast Cancer Res Treat 1995 0.82
17 Brief chemotherapy associated with extended field radiotherapy in Hodgkin's disease. Long-term results in a series of 102 patients with clinical stages I-IIIA. Eur J Cancer Clin Oncol 1988 0.82
18 Current treatment of Hodgkin's disease. Crit Rev Oncol Hematol 2000 0.81
19 [Contribution of drill-biopsies to pre-treatment investigation of breast adenocarcinomas (author's transl)]. Bull Cancer 1981 0.80
20 Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions. Histopathology 2008 0.77
21 [Primary non-Hodgkin's malignant lymphomas of the brain. Anatomoclinical and immunopathological study of 21 cases]. Sem Hop 1983 0.76
22 [Cytologic diagnosis of breast angiosarcoma]. Arch Anat Cytol Pathol 1989 0.75
23 [Breast hamartoma. Apropos of 11 cases. Review of the literature]. Sem Hop 1984 0.75
24 [Analysis of 1125 partial breast resections for diagnostic purposes. Occurrence of cancer and its histology]. Bull Cancer 1984 0.75
25 [Breast hamartomas. Apropos of 11 cases. Review of the literature]. Arch Anat Cytol Pathol 1983 0.75
26 [Histological types of 876 breast cancers according to the 1981 WHO classification]. Bull Cancer 1984 0.75
27 [Mastocytic osteoporosis without cutaneous involvement. Apropos of a case with a histomorphometric study on non-decalcified bone]. Arch Anat Cytol Pathol 1983 0.75
28 [Classification of breast cancers. Comparative review apropos of a series of 876 cancers classified according to WHO in 1981. Discussion of problems of terminology and criteria for definition of histological types]. Arch Anat Cytol Pathol 1984 0.75
29 Hodgkin's disease in the elderly. A series of 30 patients aged older than 70 years. Cancer 1984 0.75
30 [Multiple cancers: a case with 5 different tumors]. Arch Anat Cytol Pathol 1989 0.75
31 Leu-M1 antigen expression in acute leukaemias. J Pathol 1987 0.75
32 [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases]. Bull Cancer 1994 0.75
33 Adenoid cystic carcinoma of the breast. Value of immunohistochemical study in diagnosis. Tumori 1991 0.75
34 [Primary lymphosarcoma of the brain, an anatomoclinical and immunopathological study of 21 cases]. Arch Anat Cytol Pathol 1982 0.75
35 [Dedifferentiated liposarcoma. A clinico-pathologic study of 6 cases]. Ann Pathol 1992 0.75
36 [Primary malignant non-Hodgkin's lymphoma of the breast. A study of 5 cases]. Ann Pathol 1990 0.75
37 [Recurrence after treatment of breast intraductal carcinoma]. J Gynecol Obstet Biol Reprod (Paris) 1998 0.75
38 The incidence of cancer in contralateral reduction mammaplasty after mastectomy and reconstruction of the removed breast. Tumori 1986 0.75